Onego Bio Secures $40M Funding: In a major advancement, Onego Bio has successfully concluded a $40 million Series A funding, aimed at scaling its groundbreaking animal-free egg protein, Bioalbumen®. This represents a significant milestone in the Nordics, cumulatively raising Onego’s funds to $56M. Key Recent Highlights: Leadership in Precision Fermentation: With this investment, Onego Bio […]